Sorafenib With Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study

Cancers - Switzerland
doi 10.3390/cancers11070985
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy